Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.

Marium Husain,Menglin Xu,Sandipkumar Patel,Andrew Johns,Madison Grogan,Mingjia Li,Gabrielle Lopez,Abdul Miah,Rebecca Hoyd,YunZhou Liu,Mitchell Muniak,Tyler Haddad,Gabriel Tinoco,Kari Kendra,Gregory A. Otterson,Carolyn J. Presley,Daniel Spakowicz,Dwight H. Owen

Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.

2021

Marium Husain
Menglin Xu
Sandipkumar Patel
Andrew Johns
Madison Grogan
Mingjia Li
Gabrielle Lopez
Abdul Miah
Rebecca Hoyd
YunZhou Liu
Mitchell Muniak
Tyler Haddad
Gabriel Tinoco
Kari Kendra
Gregory A. Otterson
Carolyn J. Presley
Daniel Spakowicz
Dwight H. Owen

2633Background: Emerging data suggest that concomitant medications (CM) influence response to ICI. CM impact the host microbiome which may mitigate tumor-immune responsiveness. PPI use in patients ...

Keywords:

Proton-pump inhibitor
Medicine
Prior Therapy
advanced cancer
in patient
Cancer research
Concomitant
Microbiome
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations